OmniComm Systems TrialMaster® EDC Rated #1 by Clinical Research Sites Surveyed

FORT LAUDERDALE, Fla., Nov. 29, 2016 -- OmniComm Systems, Inc. (OTCQX:OMCM) received the highest grades for electronic data capture (EDC) software from clinical trial researchers, according to a survey of more than 430 site researchers from around the globe. 

Porter Research, an independent firm based in Atlanta, recently surveyed clinical research site investigators and staff from more than 390 sites in 30 countries to measure degrees of satisfaction and preference of EDC systems.

As part of the survey, site investigators selected their top choice for EDC system based on actual experience and EDC usage during clinical trials over the last two years. Additionally, survey participants rated EDC systems based on ease of use, performance and customer support. OmniComm’s TrialMaster^® EDC was the only EDC system that exceeded the average in each category.

Moreover, based upon OmniComm’s research reflecting the last two years of EDC usage, it has become clear that OmniComm is now the third-largest EDC company, as measured by the number of studies, with an 8% market share after Medidata (38%) and Oracle (InForm -  20% and Oracle Clinical & Remote Data Capture - 15%).

“We are delighted to have the site survey confirm what we have been hearing anecdotally for years — namely, that the site investigators really prefer our EDC system. We were actually surprised to see that almost 3-out-of-5 sites preferred TrialMaster EDC over the presumptive market leader,” said Kuno van der Post, senior vice president of business development, OmniComm. “Notably, our customer service and support are recognized as far superior to our larger competitors, based on the survey results. Again, this is great validation of our position in the current market as the EDC specialist.”

Survey respondents selected the following as important criteria in an EDC system: 1) Ease of data entry, 2) Simple login and navigation, 3) Overall user-system familiarity, 4) User-friendliness and 5) Easy-to-answer queries. These criteria have a direct impact on timely data entry, improved data quality, increased protocol compliance and a higher level of site-user satisfaction. According to survey results, ease of use, system performance and support are the three primary areas that affect a site user’s EDC level of satisfaction and performance.

About the Study
OmniComm commissioned the Porter Research survey sent earlier this year to site investigators worldwide. The sponsor-anonymous online survey was designed to encourage EDC site users to provide unbiased responses about EDC systems.  About 66% of respondents were study coordinators/nurses, 24% investigators, with the remainder serving in various roles. While many therapeutic classes were represented, 24% of respondents were from oncology.

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 5,000 clinical trials. For more information, visit omnicomm.com.  

Contact Info:

Dennis Constantinou 
OmniComm Systems, Inc. 
+1.954.473.1254
[email protected]